Albert Chau Selected Research

epitumomab

11/2011

Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert Chau Research Topics

Disease

4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 11/2019
1	Neoplasms (Cancer) 01/2022
1	Residual Neoplasm 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2011
1	Disease Progression 11/2011

Drug/Important Bio-Agent (IBA)

2	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 01/2017
1	Gemcitabine FDA Link 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Amino Acids FDA Link 07/2018
1	fluciclovine F-18IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 11/2011
1	Estrogen ReceptorsIBA 11/2011
1	Hormones (Hormone)IBA 11/2011
1	Estrogens (Estrogen)FDA Link 11/2011
1	AntigensIBA 11/2011
1	Letrozole (Femara)FDA LinkGeneric 11/2011
1	epitumomabIBA 11/2011

Therapy/Procedure

2	Cystectomy 01/2022 - 11/2019
2	Therapeutics 11/2019 - 01/2019
1	Transurethral Resection of Bladder 01/2022
1	Neoadjuvant Therapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2022
1	Salvage Therapy 01/2020